Country/Region

February 23, 2011

The most widely used method to test patients for TB fails to identify the disease in about half of the cases. But a long-awaited new test is raising hopes that we will be able to identify TB more effectively, get patients on treatment faster, and help reign in this deadly epidemic.

November 07, 2010

Generic versions of antiretrovirals, or ARVs, that cost a fraction of the price of brand medicines make it possible for MSF to treat 160,000 people living with HIV around the world. Eighty percent of the ARVs we use come from India, and millions of others in developing countries depend on India-made generics as well. But the European Commission has begun directing its trade policies in a way that could stamp out the production of lifesaving generics in India. MSF has launched a global public campaign to tell Europe to back off, and to honor its commitments to global health.

October 14, 2010

The Kashmir Valley has been in the midst of increasing civil unrest since June. Violent, deadly clashes between protestors and security forces have led to strict 24-hour curfews and an even more pronounced military presence on the streets, the combination of which has kept people from accessing much-needed mental health care. MSF has been providing psychological care in Kashmir since 2002 and since June the team has had to adjust its strategy to in order to reach those who need help the most.

April 01, 2010

Follow the story of a malnourished child in Bihar State, one of the poorest areas of India. Also: India's generics industry is under threat; MSF treats gunshot victims in Southern Sudan; and alarmingly high numbers of female migrants in Morocco have been victims of sexual violence.

February 01, 2008

In this edition, reports on how a neglected disease continues to cause blindness in people living with HIV/AIDS in Southeast Asia, on India's hidden war in Chhattisgarh state, and on the evolution of MSF's response to post-election violence in Kenya.